Multiomic Analysis Identifies a High-Risk Signature That Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl,Matthew E. Stokes,Joseph P. Novak,Allison M. Bock,Sana Khan,Melissa A. Hopper,Jordan E. Krull,Abigail R. Dropik,Janek S. Walker,Vivekananda Sarangi,Raphael Mwangi,Maria Ortiz,Nicholas Stong,C. Chris Huang,Matthew J. Maurer,Lisa Rimsza,Brian K. Link,Susan L. Slager,Yan Asmann,Patrizia Mondello,Ryan Morin,Stephen M. Ansell,Thomas M. Habermann,Thomas E. Witzig,Andrew L. Feldman,Rebecca L. King,Grzegorz Nowakowski,James R. Cerhan,Anita K. Gandhi,Anne J. Novak BLOOD CANCER JOURNAL（2024）
AI 理解论文
溯源树
样例
